Have your own idea? Try our Stock Screener
Hong Kong (HSI) Healthcare Services Industry Analysis
UpdatedJul 05, 2026
DataAggregated Company Financials
Companies61
- 7D2.5%
- 3M-38.5%
- 1Y-26.6%
- YTD-29.4%
The Healthcare Services industry is up 2.5% in the last week, with Sinopharm Group up 6.0%. In the same time, Bayzed Health Group was down 36%. In the past year, the industry is down 27%. Looking forward, earnings are forecast to grow by 18% annually.
Industry Valuation and Performance
Has the Hong Kong Healthcare Services Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sun, 05 Jul 2026 | HK$134.4b | HK$785.1b | HK$10.7b | 14.3x | 12.5x | 0.2x |
| Tue, 02 Jun 2026 | HK$149.4b | HK$787.3b | HK$10.8b | 13.6x | 13.9x | 0.2x |
| Thu, 30 Apr 2026 | HK$171.9b | HK$780.1b | HK$10.7b | 15.4x | 16.1x | 0.2x |
| Sat, 28 Mar 2026 | HK$189.0b | HK$770.4b | HK$9.3b | 11.3x | 20.3x | 0.2x |
| Mon, 23 Feb 2026 | HK$161.4b | HK$766.3b | HK$9.3b | 11.5x | 17.3x | 0.2x |
| Wed, 21 Jan 2026 | HK$161.1b | HK$759.1b | HK$9.2b | 11.9x | 17.5x | 0.2x |
| Fri, 19 Dec 2025 | HK$155.9b | HK$745.9b | HK$9.0b | 11.6x | 17.3x | 0.2x |
| Sun, 16 Nov 2025 | HK$179.6b | HK$739.0b | HK$8.9b | 13.1x | 20.1x | 0.2x |
| Tue, 14 Oct 2025 | HK$179.6b | HK$738.4b | HK$8.3b | 12.7x | 21.7x | 0.2x |
| Thu, 11 Sep 2025 | HK$235.3b | HK$824.0b | HK$11.5b | 13.1x | 20.5x | 0.3x |
| Sat, 09 Aug 2025 | HK$228.1b | HK$826.0b | HK$13.0b | 13.9x | 17.5x | 0.3x |
| Mon, 07 Jul 2025 | HK$212.1b | HK$827.4b | HK$13.0b | 12.4x | 16.3x | 0.3x |
| Wed, 04 Jun 2025 | HK$234.4b | HK$808.7b | HK$10.8b | 12.6x | 21.8x | 0.3x |
| Fri, 02 May 2025 | HK$209.2b | HK$791.2b | HK$10.3b | 10.9x | 20.3x | 0.3x |
| Sun, 30 Mar 2025 | HK$187.5b | HK$800.4b | HK$12.3b | 12.3x | 15.3x | 0.2x |
| Tue, 25 Feb 2025 | HK$207.9b | HK$809.9b | HK$14.6b | 12.6x | 14.3x | 0.3x |
| Thu, 23 Jan 2025 | HK$198.0b | HK$809.9b | HK$14.6b | 12.7x | 13.6x | 0.2x |
| Sat, 21 Dec 2024 | HK$222.9b | HK$804.4b | HK$14.5b | 12x | 15.4x | 0.3x |
| Mon, 18 Nov 2024 | HK$220.1b | HK$813.5b | HK$14.6b | 12.9x | 15x | 0.3x |
| Wed, 16 Oct 2024 | HK$217.2b | HK$824.8b | HK$15.2b | 13.7x | 14.3x | 0.3x |
| Fri, 13 Sep 2024 | HK$190.4b | HK$835.1b | HK$15.5b | 13.2x | 12.2x | 0.2x |
| Sun, 11 Aug 2024 | HK$230.8b | HK$829.0b | HK$12.7b | 10.8x | 18.2x | 0.3x |
| Tue, 09 Jul 2024 | HK$240.6b | HK$818.4b | HK$12.5b | 10.9x | 19.3x | 0.3x |
| Thu, 06 Jun 2024 | HK$258.8b | HK$821.3b | HK$12.5b | 12.3x | 20.7x | 0.3x |
| Sat, 04 May 2024 | HK$255.9b | HK$822.9b | HK$12.5b | 12.1x | 20.4x | 0.3x |
| Mon, 01 Apr 2024 | HK$227.7b | HK$822.5b | HK$12.7b | 11.8x | 17.9x | 0.3x |
| Wed, 28 Feb 2024 | HK$249.5b | HK$815.0b | HK$12.0b | 14.9x | 20.7x | 0.3x |
| Fri, 26 Jan 2024 | HK$235.5b | HK$817.7b | HK$12.0b | 15x | 19.6x | 0.3x |
| Sun, 24 Dec 2023 | HK$235.5b | HK$820.7b | HK$12.5b | 15x | 18.9x | 0.3x |
| Tue, 21 Nov 2023 | HK$259.2b | HK$814.4b | HK$12.3b | 15.1x | 21.1x | 0.3x |
| Thu, 19 Oct 2023 | HK$279.2b | HK$801.8b | HK$12.3b | 13.3x | 22.7x | 0.3x |
| Sat, 16 Sep 2023 | HK$282.2b | HK$806.6b | HK$12.7b | 12.8x | 22.1x | 0.3x |
| Mon, 14 Aug 2023 | HK$287.9b | HK$779.6b | HK$11.4b | 10.5x | 25.3x | 0.4x |
| Wed, 12 Jul 2023 | HK$325.5b | HK$805.6b | -HK$115,494,417.00 | 11.7x | -2818.6x | 0.4x |
Price to Earnings Ratio
-2818.6x
Current Industry PE
- Investors are pessimistic on the Hong Kong Healthcare industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The industry is trading at a PE ratio of 12.5x which is higher than its 3-year average PE of -69.3x.
- The industry is trading close to its 3-year average PS ratio of 0.27x.
Past Earnings Growth
- Total earnings for the Healthcare industry have gone up over the last three years, and the industry is now profitable.
- Revenues have remained mostly flat. This means that the industry has become more efficient since profits are increasing while sales have been flat.
Industry Trends
Which industries have driven the changes within the Hong Kong Healthcare industry?
| HK Market | 1.13% | |
| Healthcare | 13.75% | |
| Healthcare Services | 2.50% | |
| Healthcare Distributors | 5.47% | |
| Healthcare Services | 3.37% | |
| Managed Healthcare | 0% | 0 |
| Healthcare Facilities | -5.85% | |
Industry PE
- Investors are most optimistic about the Healthcare Services industry which is trading above its 3-year average PE ratio.
- Analysts are expecting annual earnings growth of 35.1%, which is higher than its past year's earnings decline of 30.1% per year.
- Investors are most pessimistic about the Healthcare Distributors industry, which is trading below its 3-year average of 12.1x.
Forecasted Growth
- Analysts are most optimistic on the Healthcare Services industry, expecting annual earnings growth of 35% over the next 5 years.
- This is better than its past earnings decline of 30% per year.
- In contrast, the Healthcare Distributors industry is expected to see its earnings grow by 9.0% per year over the next few years.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| 1099 Sinopharm Group | HK$16.74 | 6.0% +HK$3.0b | -9.6% | PE6.4x | |
| 2273 Gushengtang Holdings | HK$30.46 | 21.2% +HK$1.1b | -11.1% | PE16x | |
| 9885 YSB | HK$4.80 | 17.9% +HK$498.0m | -47.8% | PE18.5x | |
| 2666 Genertec Universal Medical Group | HK$4.62 | 5.2% +HK$463.3m | -22.7% | PE3.7x | |
| 6078 Hygeia Healthcare Holdings | HK$9.47 | 8.6% +HK$459.2m | -38.2% | PE30.5x |